|
⚲
|
| Keyboard |
| Exome Asset Management LLC
✚
|
|
|---|---|
| CRD # | 304585 |
| SEC # | 801-121896 |
| CIK # | 0002011932 |
| AUM | 548.6 M (2026-03-27) |
| Employees | 10 (60% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-403-3900 |
| Address | 330 Madison Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| In the News | |
|---|---|
| Tue, 28 Jul 2026 | Exome Asset Management LLC Takes $2.95 Million Position in Monte Rosa Therapeutics, Inc. $GLUE — MarketBeat |
| Tue, 02 Jun 2026 | Wave Life Sciences Faces Investor Headwinds as Exome Asset Management Exits $5.5 Million Stake - Guidance Downgrade Alert — dars.gov.et |
| CIK | Period |
|---|---|
| 0002011932 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 14.6 | ||
| UNUM Therapeutics Inc | 10.7 | ||
| Imara Inc | 8.6 | ||
| ISIS Pharmaceuticals Inc | 8.3 | ||
| Guardant Health Inc | 7.6 | ||
| Cytokinetics Inc | 6.8 | ||
| Lilly Eli & Co | 6.4 | ||
| Alumis Inc | 6.2 | ||
| Bridgebio Pharma Inc | 5.0 | ||
| Vera Therapeutics Inc | 4.6 | ||
| Insmed Inc | 4.4 | ||
| Wellpoint Inc | 4.3 | ||
| Agios Pharmaceuticals Inc | 4.2 | ||
| United Therapeutics Corp | 4.2 | ||
| Helix Acquisition Corp | 4.0 | ||
| Natera Inc | 3.7 | ||
| Rhythm Pharmaceuticals Inc | 3.5 | ||
| UnitedHealth Group Inc | 3.5 | ||
| Verastem Inc | 3.4 | ||
| 10X Genomics Inc | 3.3 | ||
| Boston Scientific Corp | 3.0 | ||
| Alkermes PLC | 3.0 | ||
| Monte Rosa Therapeutics Inc | 3.0 | ||
| Intuitive Surgical Inc | 2.9 | ||
| Adagene Inc | 2.9 | ||
| Arrowhead Research Corp | 2.9 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Emerging Markets Healthcare Partners LLC | [2019-08-28] | 92.3 M | |
| Filed 2019-06-21 (D/A) · Exemption 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Worldwide Healthcare Partners LLC | [2019-08-28] | 200.3 M | |
| Filed 2019-06-21 (D/A) · Exemption 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 548.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 548.6 |
| By Discretionary | ||
| Discretionary | 6 | 548.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 548.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 548.6 | |
| Total | 6 | 548.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Samuel Isaly | Executive Officer | 21 | 3 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002011932] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 5493004D4EX5KUUF8I75 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Harraden Circle Investments LLC
✚
|
NY | 562.9 M |
|
Canaras Capital Management LLC
✚
|
NY | 561.0 M |
|
Spruce Street Capital LP
✚
|
NY | 555.9 M |
|
Qvidtvm Management LLC
✚
|
TX | 555.8 M |
|
Avalon Global Asset Management LLC
✚
|
CA | 553.8 M |
|
Northern Right Capital Management LP
✚
|
CT | 552.8 M |
|
TSW II Capital Advisors LLC
✚
|
TN | 544.5 M |
|
Euphrates Advisors LLC
✚
|
DC | 539.0 M |
|
Antara Capital LP
✚
|
NY | 537.4 M |
|
Ninth Avenue Capital LP
✚
|
MO | 536.0 M |